{"created":"2023-05-15T14:47:01.610513+00:00","id":64502,"links":{},"metadata":{"_buckets":{"deposit":"dbc52f9b-fac7-4156-a95b-412522c02fb4"},"_deposit":{"created_by":1,"id":"64502","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"64502"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00064502","sets":["10:29"]},"author_link":["635821","635825","635819","635824","635818","635817","635822","635823","635820"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2011-11-19","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"[目的]\n子宮頸癌に対するImage-Guided Brachetherapy (IGBT)のDVHパラメータと局所制御との関連を検討した。\n\\n[対象および方法]\n放医研で2008年から2010年にIGBTを行い、半年以上経過観察をした子宮頸癌症例43例を対象とした。年齢は30-88歳（平均60歳）、臨床病期はI/II/III/IV期:10/17/11/5例、腫瘍径は4cm未満/以上:8/35であった。放射線治療は外部照射50Gy（全骨盤照射20-40Gy後中央遮蔽）および腔内照射（A点線量24Gy/4Fr)を原則とした。腔内照射時にCTを搾えいし、GEC-ESTROの推奨に基づいてHR-CTVの輪郭をとり、HR-CTV D90を計算した。外部照射と腔内照射を合算した総線量はLQモデル（a/B=10)を用いてEQD2に換算し、総HR-CTV D90と局所制御の関連を検討した。\n\\n[結果]\n局所制御の有無を腫瘍径およびHR-CTV D90で検討すると、腫瘍径4cm未満の症例ではHR-CTV D90の値（49-89GyEQD2)に関わらず全例で局所制御された。一方、腫瘍径4cm以上の症例ではHR-CTV D90が60GyEQD2以上の30例2年局所制御率が97%であったのに対して、60GyEQD2未満の5症例のそれは40%と有意に低かった(p=0.0003)。\n\\n[結論]\n子宮頸癌に対するIGBTにおいて腫瘍径4cm以上の症例ではHR-CTV D90と局所制御との間には有意な相関が認められ、本パラメータは有効な予後予測因子であることが示唆された。","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"日本放射線腫瘍学会　第２４回学術大会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"加藤, 真吾"}],"nameIdentifiers":[{"nameIdentifier":"635817","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"安藤, 謙"}],"nameIdentifiers":[{"nameIdentifier":"635818","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"若月, 優"}],"nameIdentifiers":[{"nameIdentifier":"635819","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"清原, 浩樹"}],"nameIdentifiers":[{"nameIdentifier":"635820","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鎌田, 正"}],"nameIdentifiers":[{"nameIdentifier":"635821","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加藤 眞吾","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"635822","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"安藤 謙","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"635823","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"若月 優","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"635824","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鎌田 正","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"635825","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"子宮頸癌に対するImage Guided BracheytherapyにおけるDVHパラメーターと局所制御の関係","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"子宮頸癌に対するImage Guided BracheytherapyにおけるDVHパラメーターと局所制御の関係"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-02-15"},"publish_date":"2012-02-15","publish_status":"0","recid":"64502","relation_version_is_last":true,"title":["子宮頸癌に対するImage Guided BracheytherapyにおけるDVHパラメーターと局所制御の関係"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:10:53.063690+00:00"}